SIM
ASMB icon

Spark Investment Management’s Assembly Biosciences ASMB Stock Holding History

Spark Investment Management’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,592
Closed -$187K – 544
2019
Q3 		$187K Hold
1,592
– – 0.02% 341
2019
Q2 		$257K Buy
+1,592
New +$303K 0.02% 438
2015
Q2 		– Sell
-1,492
Closed -$236K – 664
2015
Q1 		$236K Buy
+1,492
New +$202K 0.03% 521
2013
Q4 		– Sell
-325
Closed -$56K – 647
2013
Q3 		$56K Buy
+325
New +$49.8K 0.01% 539

Other funds holding ASMB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Spark Investment Management's ASMB Position: Q4 2019 in Review

Spark Investment Management sold out of Assembly Biosciences (ASMB) in Q4 2019, closing a stake of 1,592 shares — an estimated $187K sold.

Spark Investment Management first reported a position in ASMB in Q3 2013 and held it in 4 quarters. The position peaked at $257K in Q2 2019. 100 funds tracked by Wall St. Rank hold ASMB as of Q4 2019.

  • Spark Investment Management reported no remaining Assembly Biosciences position as of Q4 2019 after selling out during the quarter.
  • Spark Investment Management sold 1,592 Assembly Biosciences shares in Q4 2019, an estimated $187K.
  • Spark Investment Management first reported a position in Assembly Biosciences in Q3 2013 and held it in 4 quarters.
  • Spark Investment Management's Assembly Biosciences position peaked at $257K in Q2 2019.
  • 100 funds tracked by Wall St. Rank held Assembly Biosciences as of Q4 2019.

Based on Spark Investment Management's 13F filing for Q4 2019, filed 11 Feb 2020.